The incidence of Crohn's disease is increasing in many Asian countries, but considerable differences in genetic susceptibility have been reported between Western and Asian populations. This study aimed to fine-map 23 previously reported Crohn's disease genes and identify their interactions in the Chinese population by Illuminabased targeted capture sequencing. Our results showed that the genetic polymorphism A>G at rs144982232 in MST1 showed the most significant association (P = 1.78 9 10 À5 ; odds ratio = 4.87). JAK2 rs1159782 (T>C) was also strongly associated with Crohn's disease (P = 2.34 9 10 À4 ; odds ratio = 3.72). Gene-gene interaction analysis revealed significant interactions between MST1 and other susceptibility genes, including NOD2, MUC19 and ATG16L1 in contributing to
| INTRODUCTION
Crohn's disease is one of the two major forms of inflammatory bowel diseases (IBD) characterized by chronic and relapsing inflammation in the gastrointestinal tract. Crohn's disease has long been thought to be uncommon in Asian countries. However, the incidence of Crohn's disease has been rapidly increasing in Asian countries as seen in many recent epidemiological studies. 1, 2 In this regard, China has the highest incidence of IBD in Asia within the Asia-Pacific Crohn's and Colitis Epidemiologic Study Group.
Genetic susceptibility, gut microbiota and environmental factors act synergistically in the pathogenesis of Crohn's disease. Although more than 140 susceptibility loci of Crohn's disease in Caucasians have been identified by genome-wide association studies (GWASs) and meta-analyses, 4-9 considerable differences in genetic susceptibility to Crohn's disease have been reported between Western and Asian populations. Moreover, the heritability of Crohn's disease in Asian populations has not been fully explained. 5, 6 In particular, the well-established Caucasian Crohn's disease susceptibility genes, such as NOD2, ATG16L1 and PTPN, showed a lack of association in the Asian populations. 6, 8, [10] [11] [12] [13] [14] [15] Inconsistent results on IL23R and IRGM were also reported. 16, 17 Recent genetic studies in Korean and Japanese populations further revealed new Crohn's disease susceptibility loci (eg rs11235604 in ATG16L2 and rs7329174 in ELF1) that
were not significantly associated with disease status in Western populations. [18] [19] [20] This may be in part related to heterogeneity in effect size (eg TNF-SF15 and ATG16L), differences in risk allele frequency in some of the loci (eg CARD15/NOD2) or altered gene-microbiota and gene-gene interactions across different populations. 21 Collectively, these findings underpinned different genetic architectures in different ethnicities in determining genetic risk for
Crohn's disease.
The impact of new loci underlying susceptibility to Crohn's disease cannot be determined until causal variants are identified by fine mapping via directed sequencing. Moreover, it is imperative to determine whether Crohn's disease susceptibility genes identified in Europeans are also associated with disease state in non-European ancestry populations. 22 To address whether genes previously reported in Caucasian populations contribute to Crohn's disease in the Chinese population and their effect sizes, we performed finemapping analysis using next-generation targeted capture sequencing.
Moreover, as interactions among multiple genes could impact on the patients' disease phenotype, we aimed to identify interactions among the targeted captured genes to provide insight into the genetic of Crohn's disease.
2 | ME TH ODS 
| ImmunoChip data set
The design and genotyping of the ImmunoChip have been previously described. 21 In brief, the ImmunoChip is an Illumina Infinium microar- Kong Chinese subjects on the ImmunoChip data set. Quality control was performed as described. 21 The cohort includes 235 controls and 531 IBD cases, including 388 patients with Crohn's disease.
| Statistical analysis
The SNPs from targeted sequencing had low to rare minor allele frequencies (MAFs). The sequence kernel association test (SKAT) is an effective method to detect association of the sequencing data to disease phenotypes. 23, 24 The method uses a linear mixed model and performs variance component score test. 24 For epistasis evaluation, a robust W-test was used to evaluate SNP-SNP interactions. 25 The W-test is testing for the difference in genotype distributions formed by a SNP pair in case and control groups. The test follows a chi-squared distribution of which the degrees of freedom is bootstrap-estimated from the data. Therefore, the method is able to correct for bias in distributions due to complicated genetic architecture and return robust estimates. 25 The SKAT and W-test were conducted using R packages. 23, 25 The LocusZoom tool was used to draw SNPs Manhattan plot in a specific region and provided a detailed view of the P-value distribution within a gene. 26 A SNP or an interaction pair was significant if its P-value was smaller than Bonferroni-corrected alpha of 5%. Expression quantitative trait loci (eQTL) analysis was carried out using the Genotype-Tissue Expression database. 27 
| Power calculation
The power of an association study depends on the sample size, effect size of a variant and its allele frequency. Assuming findings from a previously validated SNP (rs2241880) in ATG16L1 with an odds ratio of 0.69 and a minor allele frequency of 45%, our study had 86.2% power to detect such a variant with an a-error rate of 5%. Alternatively, our study had at least 80% power to detect a variant with odds ratio of 1.5 at a MAF of 20%.
3 | RESULTS
| Patient characteristics, quality control and SNP calling
A total of 262 patients with Crohn's disease and 323 controls were included. The mean age was 43.6 and 55.9 years in the case and control groups, respectively. About half of the subjects were female (45.9%). Table S1 summarizes the basic characteristics of the cases and controls. DNA samples were collected from all patients for targeted capture sequencing, generating a genotype data set of 2046
SNPs. Four subjects were excluded because of empty data files. Targeted capture of all DNA samples was completed with an average sequencing depth (on target) of >50 and a coverage of >99.7% (Table S2) (Table S3 ).
| Novel associations of MST1 rs144982232 with
Crohn's disease
Sequence kernel association test analysis identified one locus, namely the rs144982232 in MST1 (A>G, P = 1.78 9 10 À5 , odds ratio = 4.87), which was significantly associated with Crohn's disease after controlling for multiple testing by Bonferroni method (Tables 1   and S6 (Table S4 ). For genegene interactions, the top pair MST1-JAK2 had significant P-values in the original and validation data set (original: P = 9.44 9 10
À11
; validation IBD: P = 7.28 9 10
À5
; validation Crohn's disease:
). The remaining three pairs that exhibited consistent small P-values were NOD2-JAK2, IL23R-MST1 and MST1-PTGER4 (Table S5 ).
| DISCUSSION
Although the prevalence and incidence of Crohn's disease are higher in Western countries, they continue to rise in Asia, especially in China. It is anticipated that the number of cases of IBD in Asia might overtake that of the Western world by 2025. 29 In this study, we fine-mapped 23 known Crohn's disease susceptibility genes to identify the causal variants and delineate the relative contribution of these variants to Crohn's disease in the Chinese population. Identification of causal variants is key to understanding the molecular mechanism by which disease susceptibility genes contribute to pathogenesis as well as formulating novel therapeutic strategies. A major advantage of using targeted capture sequencing for fine mapping is the directed focus on genes of interest. Therefore, unlike GWAS, our study was not restricted by the conventional genomewide significance threshold as a result of fewer multiple testing.
In the targeted captured regions, the synonymous SNP (ie rs144982232) in MST1 was most significantly associated with html), we found that although the SNP A>G at rs144982232 did not significantly affect the secondary structure of MST1 mRNA, the corresponding nucleotide change occurred in the loop region of the predicted RNA stem-loop structure ( Figure S3 ), which is implicated in the control of RNA-protein complex formation. 31, 32 MST1, also known as MSP, is involved in regulating the innate immune response to infections and cellular stress. It binds to the receptor RON to trigger macrophage chemotaxis and activation.
31
MST1 is a serum protein that circulates in the blood as an inactive single-chain precursor (pro-MST1) comprising two chains, a and b.
34
MST1 was first recognized as a Crohn's disease risk gene (odds ratio = 1.20) in a GWAS where a single non-synonymous SNP rs3197999 corresponding to the amino acid substitution R689C in the b-chain was identified. 35 The mechanism of this potential causal variant for Crohn's disease was controversial. 36, 37 One study showed that R689C polymorphism had no impact on the ability of MST1 to bind to or signal through RON, whereas carriers of the 689C polymorphism had lower concentrations of MST1 in their serum, which could possibly increase Crohn's disease risk. 36 However, another study showed that the affinity to RON of MST1 with the 689C polymorphism was approximately 10-fold lower than that of the wildtype MST1 and the thermal stability of the mutant MST1 was slightly lower than that of wild-type MST1. 37 However, rs3197999
did not show up as a significant SNP in our study. Instead, the SNP A>G at rs144982232 showed the strongest association with Crohn's disease in our cohort (odds ratio = 4.87; P = 1.78 9 10
À5
). Early
GWASs showed that with the exception of NOD2, the typical effect size of Crohn's disease susceptibility locus was modest (odds Crohn's disease has to be consolidated with an independent Chinese cohort.
The genetic heterogeneity between East Asians and Europeans at alleles of large effect could be exemplified by NOD2. The contribution of NOD2 rare variants to risk and site of Crohn's disease was well studied and explained in Caucasians, with 4 mutations (P268S, R702W, G908R and 3020insC) showing the strongest association. [40] [41] [42] However, a previous study demonstrated no association of NOD2 R702W and G908R with IBD in Chinese patients. 43 In line with pre- 45 it is hopeful that JAK inhibition will benefit this subset of patients with genetic susceptibility in JAK2.
From epistasis analysis, we found the most connected gene with other SNPs that synergistically conferred risks to Crohn's disease was MST1. In particular, MST1 rs144982232 showed interactions with other IBD genes, including JAK2, NOD2, ATG16L, VDR and STAT3, indicating a more complicated role of MST1 in Crohn's disease pathogenesis. Among these pairs, the top significant interactions were with JAK2, NOD2 and MUC19. To this end, MST1-JAK2 interaction has also been identified in ulcerative colitis, 46 another major form of IBD. NOD2 polymorphisms could also modulate innate immune response 47 whereas MUC19 deficiency could impair mucus production, 48 both of which are important for mucosal barrier function and the control of subsequent invasion of commensals or opportunistic pathogens. The co-involvement of NOD2, JAK2, MUC19 and MST1 in mucosal defence and inflammation in Crohn's disease therefore deserves further study.
Another noteworthy observation is that VDR was centred by MUC19, MST1, ATG16L1 and NOD2, which synergistically contributed to Crohn's disease risk. The association between VDR and Crohn's disease has been supported by multiple studies. [49] [50] VDR, which codes for vitamin D receptor, is engaged in NOD2 gene transcription and signalling through NOD2 to induce expressions of b-defensin 2 and cathelicidin. 51 Variants or deletion of VDR may also change the microbiota and reduce the host defence through diminishing the production of microbicidal peptides as well as ATG16L1. 52,53 However, the interaction network among genes of interest that leads to Crohn's disease needs to be elucidated in-depth in future studies.
Taken together, our data suggested that a novel locus in MST1 is 
